Patient Recruitment and Enrollment in Clinical Trials
Recruiting participants for clinical trials can be a bigger challenge than conducting the trials themselves. A delay in recruitment prolongs the study's timeline, pushing back the treatment's market availability. Take a look at the infographic below to grasp how the public discovers clinical trials, motivations for participation, and the hurdles faced in enrollment.Patient Recruitment and Enrollment Infographic
Discovering Clinical Trials
72% of participants are existing patients, while twenty-eight percent are new.
Top sources of clinical trial information:
Fifty-eight percent from primary care physicians
40% from online registries
30% from search engines
Nineteen percent from primary care nurses
19% from pharmaceutical companies
Motivations for Participation
Top perceived benefits:
Twenty-six percent to advance medicine
36% to improve others' here lives
15% to improve their condition
Eight percent as the best treatment option
5% for monetary compensation
Factors influencing participation:
Sixty percent physical location
63% confidentiality
Seventy-three percent types of procedures
Seventy-five percent study purpose
83% potential risks and benefits
Enrollment Challenges
37% of sites under-enroll, with 11% failing to enroll any patients.
Doubling original timelines helps 90% of trials meet enrollment goals.
Seventy percent of the public haven't considered clinical trials, with nineteen percent unwilling to participate and 7% unsure.
Top perceived risks:
40% side effects
Thirty-three percent overall health risks
Seven percent receiving placebo
Seven percent stopping beneficial treatments
40% lack confidence in finding a suitable study, and 70% seldom consider clinical trials when discussing treatment options.
However, there's optimism for improvement: 74% are open to discussing trial participation in online peer communities, and ninety-four percent of volunteers would participate again.
To learn more visit our website at https://recruitqualified.com
Patient Recruitment and Enrollment in Clinical Trials